Raising Healthcare Standards

Contact Us | Glossary | Site Map | Links | Help | Accessibility | Low Graphics |  Text Size: A |  A+ |  A++

Advanced Search

main navigation: 
"Consistently good healthcare which continually improves is our aim."

Anaesthesia

DateTitle
Jun-07 Anaesthesia - Care Before, During and After Anaesthesia
Jul-03 Anaesthesia: Care Before, During and After Anaesthesia - Standards
Jul-03 Anaesthesia: Care before, during and after anaesthesia
Back to top ˆ

Arthritis

DateTitle
Apr-08 NICE STA Guidance 140 and 141
Nov-07 Clinical Indicators 2007
Oct-07 NICE (Multiple) Technology Appraisal Guidance No 130: Adalimumab, etanercept and infliximab for the
Jul-06 NICE Technology Appraisal Guidance No 104 Etanercept and infliximab for psoriatic arthritis
Nov-03 NICE Technology Appraisal Guidance No 72 - use of anakinra for rheumatoid arthritis
Mar-02 NICE Technology Appraisal Guidance - No. 35 - Etanercept for the treatment of juvenile idiopathic ar
Sep-01 The use of cyclo-oxegenase (Cox) II selective inhibitors for osteoarthritis and rheumatoid arthritis
Back to top ˆ

Asthma

DateTitle
May-08 Asthma Services for Children and Young People (incorporating Clinical Governance and Risk Management
Mar-08 NICE (Multiple) Technology Appraisal Guidance No 138
Dec-07 Nice (Multiple) Technology Appraisal Guidance No: 131 and No: 132
Nov-07 NICE (Single) Technology Appraisal Guidance No 133 – Omalizumab for severe allergic asthma
Mar-07 Asthma Services for Children and Young People Clinical Standards
Aug-06 Report of Consultation Events with Children, Young People and Parents
Apr-06 Asthma Services for Children - Draft Clinical Standards
Apr-06 Asthma Attack - Targeting Emergency Asthma Contacts in Children
Mar-02 NICE Technology Appraisal Guidance - No. 38 Inhaler devices for routine treatment of chronic asthma
Back to top ˆ

Blood

DateTitle
Aug-08 (Multiple)TA Guidance No 156 – Routine antenatal anti-D prophylaxis for women who are rhesus D-
Jul-08 Blood Transfusion
May-08 NICE (Multiple) Technology Appraisal Guidance No 142 – Epoetin alfa, epoetin beta and darbepoetin al
Aug-07 Evidence Note 17 Recombinant factor VIIa (rFVIIa) for people with haemophilia who develop inhibitors
Oct-06 Clinical Standards - Blood Transfusion
Aug-04 Safe and Effective Transfusion in Scottish Hospitals - The Role of the Transfusion Nurse Specialist
Aug-04 Report of the Steering Group on the Safe, Effective and Efficient Use of Blood Components
Back to top ˆ

Cancer

DateTitle
Jul-08 Standards for Cancer Services (Core, lung, ovarian, breast and bowel)
Jun-08 NICE Single Technology Appraisal Guidance No 145
May-08 NICE (Multiple) Technology Appraisal Guidance No 142 – Epoetin alfa, epoetin beta and darbepoetin al
Apr-08 Determining the most clinically and cost-effective way of implementing digital mammography services
Feb-08 NICE STA 137 Rituximab for non-Hodgkin’s lymphoma
Jan-08 NICE (Multiple) TAG 135 Pemetrexed
Oct-07 NICE Technology Appraisal Guidance No 129: Bortezomib monotherapy for relapsed multiple myeloma
Aug-07 Computed Tomography (CT) Colonography HTA Scoping Report
Aug-07 NICE STA 124: Pemetrexed
Apr-07 Draft Core Standards for Cancer Services
Mar-07 Bowel Screening Programme Clinical Standards
Feb-07 NICE STA 119: Fludarabine monotherapy - first-line treatment of chronic lymphocytic leukaemia
Jan-07 NICE (Multiple) Technology Appraisal Guidance No 118 Bevacizumab and cetuximab
Jan-07 NICE (Single) Technology Appraisal Guidance No 116 Gemcitabine
Dec-06 Evidence Note 15
Nov-06 NICE Technology Appraisal Guidance No 112 Breast Cancer
Sep-06 NICE Single Technology Appraisal No 109: Docetaxel for the adjuvant treatment of early node-positive
Sep-06 NICE Single Technology Appraisal No108: Paclitaxel for the adjuvant treatment of early node-positive
Aug-06 NICE Technology Appraisal Guidance No 105 - Laparoscopic surgery for colorectal cancer
Jun-06 NICE Guidance No 101 - Docetaxel for the treatment of hormone-refractory metastatic prostate cancer
Apr-06 NICE Guidance 100 Oxaliplatin and capecitabine - adjuvant treatment of colorectal cancer
Aug-05 NICE Technology Appraisal 93 - Colorectal cancer (advanced) - irinotecan, oxaliplatin, raltitrexe
May-05 NICE Technology Appraisal Guidance 91 - Treatment of advanced ovarian cancer
Jul-04 Evidence Note 7: Comparison of digital mammography and film screen mammography
Apr-04 Best Practice Statement - Skincare of Patients Receiving Radiotherapy
Apr-04 The Management of Pain in Patients with Cancer
Nov-03 Breast Screening - National Overview
Nov-03 Breast Screening - North
Nov-03 Breast Screening - North East of Scotland
Nov-03 Breast Screening - South East
Nov-03 Breast Screening - South West
Nov-03 Breast Screening - Tayside
Nov-03 Breast Screening - West
Nov-03 Cervical Screening - Argyll & Clyde
Nov-03 Cervical Screening - Ayrshire & Arran
Nov-03 Cervical Screening - Borders
Nov-03 Cervical Screening - Dumfries & Galloway
Nov-03 Cervical Screening - Fife
Nov-03 Cervical Screening - Forth Valley
Nov-03 Cervical Screening - Grampian
Nov-03 Cervical Screening - Greater Glasgow
Nov-03 Cervical Screening - Highland
Nov-03 Cervical Screening - Lanarkshire
Nov-03 Cervical Screening - Lothian
Nov-03 Cervical Screening - National Overview
Nov-03 Cervical Screening - Orkney
Nov-03 Cervical Screening - Shetland
Nov-03 Cervical Screening - Tayside
Nov-03 Cervical Screening - Western Isles
Oct-03 NICE Technology Appraisal Guidance No 70 - Use of imatinib for chronic myeloid leukaemia
Sep-03 NICE Technology Appraisal Guidance 65 - the use of rituximab for aggressive non-hodgkin's lymphoma
May-03 NICE Technology Appraisal Guidance 61 - use of treatments for colorectal cancer
May-03 NICE Technology Appraisal Guidance No 62 - the use of capecitabine for breast cancer
Dec-02 NICE Technology Appraisal Guidance No 54 - The use of vinorelbine for the treatment of advanced brea
Dec-02 Breast Screening Standard 2002
Oct-02 Positron emission tomography (PET) imaging in cancer management
Sep-02 NICE Technology Appraisal Guidance No 50 - The use of imatinib for chronic myeloid leukaemia
Jul-02 NICE Technology Appraisal Guidance - No. 45 Guidance on the use of pegylated liposomal doxorubicin h
Apr-02 Lung cancer services - Argyll & Clyde
Apr-02 Lung cancer services - Ayrshire & Arran
Apr-02 Lung cancer services - Borders
Apr-02 Lung cancer services - Dumfries & Galloway
Apr-02 Lung cancer services - Fife
Apr-02 Lung cancer services - Forth Valley
Apr-02 Lung cancer services - Grampian
Apr-02 Lung cancer services - Greater Glasgow (North)
Apr-02 Lung cancer services - Greater Glasgow (South)
Apr-02 Lung cancer services - Highland
Apr-02 Lung cancer services - Lanarkshire
Apr-02 Lung cancer services - Lothian
Apr-02 Lung cancer services - Lothian (West)
Apr-02 Lung cancer services - Orkney
Apr-02 Lung cancer services - Shetland
Apr-02 Lung cancer services - Tayside
Apr-02 Lung cancer services - Western Isles
Mar-02 NICE Technology Appraisal Guidance - No. 34 Guidance on the use of trastuzumab (Herceptin) for the t
Mar-02 NICE Technology Appraisal Guidance - No. 37 Guidance on the use of rituximab for recurrent or refrac
Mar-02 NICE Technology Appraisal Guidance No. 33: Guidance on the use of irinotecan, oxaliplatin and raltit
Mar-02 Breast cancer services - Argyll & Clyde
Mar-02 Breast cancer services - Ayrshire & Arran
Mar-02 Breast cancer services - Borders
Mar-02 Breast cancer services - Dumfries & Galloway
Mar-02 Breast cancer services - Fife
Mar-02 Breast cancer services - Forth Valley
Mar-02 Breast cancer services - Grampian
Mar-02 Breast cancer services - Greater Glasgow (North)
Mar-02 Breast cancer services - Greater Glasgow (South)
Mar-02 Breast cancer services - Highlands
Mar-02 Breast cancer services - Lanarkshire
Mar-02 Breast cancer services - Lothian
Mar-02 Breast cancer services - Lothian (West)
Mar-02 Breast cancer services - National Overview
Mar-02 Breast cancer services - Orkney
Mar-02 Breast cancer services - Shetland
Mar-02 Breast cancer services - Tayside
Mar-02 Breast cancer services - Western Isles
Mar-02 Colorectal cancer services - Argyll & Clyde
Mar-02 Colorectal cancer services - Ayrshire & Arran
Mar-02 Colorectal cancer services - Borders
Mar-02 Colorectal cancer services - Dumfries & Galloway
Mar-02 Colorectal cancer services - Fife
Mar-02 Colorectal cancer services - Forth Valley
Mar-02 Colorectal cancer services - Grampian
Mar-02 Colorectal cancer services - Greater Glasgow (North)
Mar-02 Colorectal cancer services - Greater Glasgow (South)
Mar-02 Colorectal cancer services - Highland
Mar-02 Colorectal cancer services - Lanarkshire
Mar-02 Colorectal cancer services - Lothian
Mar-02 Colorectal cancer services - Lothian (West)
Mar-02 Colorectal cancer services - National Overview
Mar-02 Colorectal cancer services - Orkney
Mar-02 Colorectal cancer services - Shetland
Mar-02 Colorectal cancer services - Tayside
Mar-02 Colorectal cancer services - Western Isles
Mar-02 Lung cancer services - national overview
Mar-02 Ovarian cancer services - Argyll & Clyde
Mar-02 Ovarian cancer services - Ayrshire & Arran
Mar-02 Ovarian cancer services - Borders
Mar-02 Ovarian cancer services - Dumfries & Galloway
Mar-02 Ovarian cancer services - Fife
Mar-02 Ovarian cancer services - Forth Valley
Mar-02 Ovarian cancer services - Grampian Local Report
Mar-02 Ovarian cancer services - Greater Glasgow (North)
Mar-02 Ovarian cancer services - Greater Glasgow (South)
Mar-02 Ovarian cancer services - Highland
Mar-02 Ovarian cancer services - Lanarkshire
Mar-02 Ovarian cancer services - Lothian
Mar-02 Ovarian cancer services - Lothian (West)
Mar-02 Ovarian cancer services - National Overview
Mar-02 Ovarian cancer services - Orkney
Mar-02 Ovarian cancer services - Shetland
Mar-02 Ovarian cancer services - Tayside
Mar-02 Ovarian cancer services - Western Isles
Sep-01 NICE Technology Appraisal Guidance - No. 29: The use of fludarabine for B-cell chronic lymphocytic l
Sep-01 NICE Technology Appraisal Guidance - No. 30: The use of taxanes for the treatment of breast cancer
Aug-01 NICE Technology Appraisal Guidance - No. 28: Topotecan for the treatment of advanced ovarian cancer
Aug-01 NICE Technology Appraisal Guidance 26 - use of docetaxel, paclitaxel, gemcitabine and vinorelbine
Back to top ˆ

Children's Health

DateTitle
Sep-08 Developmental Co-ordination Disorder: Review Response
Sep-08 Best Practice Statement - Caring For The Child/Young Person With A Tracheostomy
May-08 Asthma Services for Children and Young People (incorporating Clinical Governance and Risk Management
Apr-08 Attention Deficit and Hyperkinetic Disorders - Services over Scotland
Jan-08 EN22 clinical and cost effectiveness of surgical insertion of grommets for otitis media in children
Dec-07 Nice (Multiple) Technology Appraisal Guidance No: 131 and No: 132
Nov-07 Developmental Co-ordination Disorder
Sep-07 Caring for children and young people in the community receiving enteral tube feeding
Aug-07 Key Findings Parents and Carers of Nasogastric and Gastrostomy Fed Children
Jul-07 ADHD – Services Over Scotland
Jun-07 Evidence Note 16: cranial orthosis treatment
Mar-07 Asthma Services for Children and Young People Clinical Standards
Feb-07 Scottish Audit of Genital Anomalies
Dec-06 Evidence Note 14
Aug-06 Report of Consultation Events with Children, Young People and Parents
Jul-06 NICE Technology Appraisal Guidance No 102 Children with conduct disorders
Jun-06 Screening hips of newborns in Scotland - HTA Scoping Report
Apr-06 Glycaemic Control in Children and Adolescents Under 15 Years of Age with Type 1 Diabetes in Scotland
Apr-06 NICE Technology Appraisal Guidance 99 Immunosuppressive therapy - renal transplantation in children
Apr-06 Asthma Services for Children - Draft Clinical Standards
Apr-06 Asthma Attack - Targeting Emergency Asthma Contacts in Children
Mar-06 NICE Technology Appraisal Guidance No 98 Methylphenidate, atomoxetine and dexamfetamine
Dec-05 Evidence Note 11: Dynamic lycra splinting for children with cerebral palsy
Jul-05 NICE Technology Appraisal Guidance No 92 ¿ HealOzone for tooth decay
May-05 Evaluating the Effectiveness of the National Special Needs System - Final Report
Sep-04 Children's Health Services Steering Group
May-04 NICE Technology Appraisal Guidance No 79 - Newer drugs for epilepsy in children
Apr-04 Review of healthcare services for children and adults with learning disabilities
Mar-04 Routine ultrasound scanning before 24 weeks of pregnancy
Mar-04 Routine ultrasound scanning before 24 weeks of pregnancy
Nov-03 NICE Technology Appraisal Guidance No 72 - use of anakinra for rheumatoid arthritis
Jan-03 Nasogastric and gastrostomy tube feeding for children being cared for in the community
Sep-02 NICE Technology Appraisal Guidance No 50 - The use of imatinib for chronic myeloid leukaemia
Sep-02 NICE Technology Appraisal Guidance No. 48 - Guidance on home compared with hospital haemodialysis fo
Jul-02 NICE Technology Appraisal Guidance - No. 46 Guidance on the use of surgery to aid weight reduction f
May-02 NICE Technology Appraisal Guidance - No. 42 Guidance on the use of human growth hormone (somatropin)
May-02 Home Oxygen Therapy for children being cared for in the community
Mar-02 NICE Technology Appraisal Guidance - No. 35 - Etanercept for the treatment of juvenile idiopathic ar
Mar-02 NICE Technology Appraisal Guidance - No. 36 Guidance on the use of etanercept and infliximab for the
Mar-02 NICE Technology Appraisal Guidance - No. 38 Inhaler devices for routine treatment of chronic asthma
Oct-01 NICE Technology Appraisal Guidance - No. 31 - The use of sibutramine for the treatment of obesity
Sep-01 The use of cyclo-oxegenase (Cox) II selective inhibitors for osteoarthritis and rheumatoid arthritis
Back to top ˆ

Clinical governance

DateTitle
Oct-08 Strathmartine Hospital Improvement Review Report
Sep-08 Best Practice Statement - Caring For The Child/Young Person With A Tracheostomy
Sep-08 Rapid review of the front-loaded model and proposed application within Scottish Ambulance Service
Jun-08 Clinical Governance & Risk Management local reports
Jun-08 Stoma Care Audit Scotland: Febuary 2008
May-08 Asthma Services for Children and Young People (incorporating Clinical Governance and Risk Management
May-08 Protocol for systematic review on provision of patient information
Apr-08 The clinical and cost effectiveness of hyperbaric oxygen therapy (HBOT)
Apr-08 Determining the most clinically and cost-effective way of implementing digital mammography services
Apr-08 The clinical and cost effectiveness of thromboelastography/thromboelastometry
Jan-08 EN22 clinical and cost effectiveness of surgical insertion of grommets for otitis media in children
Jan-08 Service delivery organistation for acute low back pain
Jan-08 Evidence note 21: Antiviral treatment for shingles and its complications in immunocompetent adults
Dec-07 Incident Reporting Culture Survey board reports
Dec-07 NHSScotland Incident Reporting Culture Study
Oct-07 Clinical Governance and Risk Management National Overview October 2007
Sep-07 Using data to improve surgical care - the surgical profiles project
Sep-07 Interim report of Clinical Governance and Risk Management review cycle
Sep-07 Protocol for review of Hyperbaric Oxygen Therapy
Aug-07 CIRIS - Clinical Improvement in Radiological Imaging Systems
Apr-07 Caring for the patient with a tracheostomy
Jun-06 A Realist Synthesis of Evidence Relating to Practice Development
Apr-06 Outcome of the Scoping for an Health Technology Assessment in Homeopathy
Mar-06 Patient group directions
Jan-06 Patient Safety - Review of Incident and Near-Miss Reporting
Jan-06 The Impact of Nursing on Patient Clinical Outcomes - Developing Quality Indicators to Improve Care
Oct-05 Clinical Governance and Risk Management - National Standards
Jun-05 Interim Review of Clinical Governance and Risk Management Arrangements in NHSScotland
Apr-05 Clinical Governance and Risk Management Draft Standards
Aug-04 Emergency Medical Admissions Scoping Group
Oct-03 Evidence Note 4: A&E department streaming system
May-03 Generic clinical governance
Oct-02 Community hospitals - Self-Assessment
Mar-02 Generic standards (reprint)
Back to top ˆ

Community care

DateTitle
Jan-03 Nasogastric and gastrostomy tube feeding for children being cared for in the community
Dec-02 The preparation of injections in near patient areas including clinical and home environments
May-02 Home Oxygen Therapy for children being cared for in the community
Back to top ˆ

Dentistry

DateTitle
Jul-05 NICE Technology Appraisal Guidance No 92 ¿ HealOzone for tooth decay
Mar-04 Draft National Standards for Dental Services
Back to top ˆ

Diabetes

DateTitle
Jul-08 NICE (Multiple) Technology Appraisal Guidance No 151
Mar-08 Diabetes National Overview Follow-up Report
Nov-07 Diabetes Follow-up Reports
Dec-06 NICE Technology Appraisal Guidance No 113
Apr-06 Glycaemic Control in Children and Adolescents Under 15 Years of Age with Type 1 Diabetes in Scotland
Jan-05 Evidence Note 8: Continuous glucose monitors in diabetes mellitus
Mar-04 Diabetes - Tayside Local Report
Mar-04 Diabetes - Argyll and Clyde Local Report
Mar-04 Diabetes - Ayrshire and Arran Local report
Mar-04 Diabetes - Borders Local Report
Mar-04 Diabetes - Dumfries and Galloway Local Report
Mar-04 Diabetes - Fife Local Report
Mar-04 Diabetes - Forth Valley Local Report
Mar-04 Diabetes - Grampian Local Report
Mar-04 Diabetes - Greater Glasgow Local Report
Mar-04 Diabetes - Highland Local Report
Mar-04 Diabetes - Lanarkshire Local Report
Mar-04 Diabetes - Lothian Local Report
Mar-04 Diabetes - National Overview
Mar-04 Diabetes - Orkney Local Report
Mar-04 Diabetes - Shetland Local Report
Mar-04 Diabetes - Western Isles Local Report
Mar-04 Diabetic Retinopathy Screening Standard
Aug-03 NICE Technology Appraisal Guidance No 63 - use of Glitazones for the treatment of type 2 diabetes
May-03 NICE Technology Appraisal Guidance 60 - guidance on the use of patient-education models for diabetes
May-03 Diabetic retinopathy screening
Feb-03 NICE Technology Appraisal Guidance 57 - use of continuous subcutaneous insulin infusion for diabetes
Dec-02 NICE Technology Appraisal Guidance No 53 - The use of long-acting insulin analogues for the treatmen
Nov-02 Overview of organisation of services for diabetic retinopathy screening
Oct-02 Diabetes - Second Edition
Apr-02 Organisation of services for diabetic retinopathy screening
Jan-02 Organisation of services for diabetic retinopathy screening
Back to top ˆ

Epilepsy

DateTitle
May-04 NICE Technology Appraisal Guidance No 79 - Newer drugs for epilepsy in children
Mar-04 NICE Guidance No. 76 - Newer drugs for epilepsy in adults
Back to top ˆ

Fatal accident

DateTitle
Sep-07 Fatal Accident Inquiries - A Guide for NHS staff
Back to top ˆ

Fractures

DateTitle
Oct-05 Effectiveness of Strategies for the Secondary Prevention of Osteoporotic Fractures in Scotland
Back to top ˆ

General Medicine

DateTitle
Sep-08 EN24: Acupuncture for low back pain
Sep-08 NICE (Multiple) Technology Appraisal Guidance No 158
Aug-08 NICE (Multiple) TA Guidance No 155 – Ranibizumab and Pegaptanib for Age-related Macular Degeneration
Aug-08 NICE SingleTechnology Appraisal Guidance No 153 - Entecavir for the treatment of chronic hepatitis B
Aug-08 Single Technology Appraisal Guidance No 154 - Telbivudine for the treatment of chronic hepatitis B
May-08 NICE (Multiple) Technology Appraisal Guidance No 143
Nov-07 Clinical Indicators 2007
Aug-06 HTA Advice The use of epoetin alfa before orthopaedic surgery in patients with mild anaemia
Aug-06 The use of epoetin alfa before orthopaedic surgery in patients with mild anaemia
Aug-06 NICE Technology Appraisal Guidance 106 Peginterferon alfa and ribavarin for mild chronic hepatitis C
Mar-06 Patient group directions
Feb-06 NICE Technology Appraisal Guidance No 96 - Hepatitis B (chronic) - adefovir dipivoxil and peginterfe
May-05 NICE Technology Appraisal Guidance 90 - Clopidogrel and modified-release dipyridamole
Feb-05 NICE Technology Appraisal Guidance No 87 - Prevention of fragility fractures in postmenopausal women
Sep-04 NICE Technology Appraisal Guidance No 84 - Drotrecogin alfa (activated) for severe sepsis
Apr-04 Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia
Jan-04 28-01-04 NICE Technology Appraisal Guidance No 75 - treatment of chronic hepatitis C
Dec-03 Organisation of Troponin Testing Services in Acute Coronary Syndromes
Aug-03 NICE Technology Appraisal Guidance 64 - use of somatropin in adults with growth hormone deficiency
Feb-03 NICE Technology Appraisal Guidance 58 - use of zanamivir, oseltamivir and amantadine for the treatme
Oct-02